Nanobiotix SA
LSE:0QAV
Nanobiotix SA
LSE:0QAV
Price:
31.8
EUR
6.85%
Market Closed
Market Cap:
€10m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Nanobiotix SA
LSE:0QAV
|
FR |
|
Arix Bioscience PLC
LSE:ARIX
|
UK |
|
A
|
Active Biotech AB publ
XBER:BTPC
|
SE |
|
G
|
Great Pacific Gold Corp
XTSX:GPAC
|
CA |
|
China Southern Airlines Co Ltd
SSE:600029
|
CN |
|
J
|
Japan Real Estate Investment Corp
F:JUA
|
JP |
|
K
|
KHD Humboldt Wedag Vermoegensverwaltungs-AG
DUS:HETA
|
DE |
Price Target
Loading...
Revenue
Loading...
Gross Profit
Loading...
Operating Income
Loading...
Pre-Tax Income
Loading...
Net Income
Loading...
Wall St Price Targets
0QAV Price Targets Summary
Nanobiotix SA
Nanobiotix SA
Wall Street analysts forecast 0QAV stock price to rise over the next 12 months.
According to Wall Street analysts, the average 1-year price target for 0QAV is 49.78 EUR with a low forecast of 35.94 EUR and a high forecast of 64.06 EUR.
Lowest Forecast
Price Target
35.94
EUR
13% Upside
Average Forecast
Price Target
49.78
EUR
57% Upside
Highest Forecast
Price Target
64.06
EUR
101% Upside
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 0QAV's stock price target?
Price Target
49.78
EUR
49.78
EUR
According to Wall Street analysts, the average 1-year price target for 0QAV is 49.78 EUR with a low forecast of 35.94 EUR and a high forecast of 64.06 EUR.
What is the Revenue forecast for Nanobiotix SA?
Projected CAGR
149%
149%
Over the last 14 years, the compound annual growth rate for Revenue has been 13%. The projected CAGR for the next 3 years is 149%.
